Tratamiento de mantenimiento en las vasculitis asociadas a anticuerpos contra citoplasma de neutrófilos (ANCA)

EUVAS Study Group, 2004 [consultado 4 Jul 2010]. Disponible en: www.vasculitis.org Luqmani, 1994, Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis, QJM, 87, 671 Hogan, 2005, Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis, Ann Intern Med, 143, 621, 10.7326/0003-4819-143-9-200511010-00005 Pagnoux, 2008, Azathioprine or methotrexate maintenance for ANCA-associated vasculitis, N Engl J Med, 359, 2790, 10.1056/NEJMoa0802311 Gayraud, 2001, Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg–Strauss syndrome: analysis of four prospective trials including 278 patients, Arthritis Rheum, 44, 666, 10.1002/1529-0131(200103)44:3<666::AID-ANR116>3.0.CO;2-A Walsh, 2010, The effects of duration of glucocorticoid therapy on relapse rate in anti-neutrophil cytoplasm antibody associated vasculitis. A meta-analysis, Arthritis Care Res (Hoboken), 62, 1166, 10.1002/acr.20176 Bosch, 2007, Treatment of antineutrophil cytoplasmic antibody associated vasculitis. A systematic review, JAMA, 298, 655, 10.1001/jama.298.6.655 Jayne, 2003, A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies, N Engl J Med, 349, 36, 10.1056/NEJMoa020286 Slot, 2004, Positive classic antineutrophil cytoplasmic antibody (C-ANCA) titer at switch to azathioprine therapy associated with relapse in proteinase-3-related vasculitis, Arthritis Rheum, 51, 269, 10.1002/art.20234 Pagnoux, 2008, Azathiprine or methotrexate maintenance for ANCA-associated vasculitis, N Eng J Med, 359, 2790, 10.1056/NEJMoa0802311 De Groot, 2005, Randomized Trial of Cyclophosphamide Versus Methotrexate for Induction of Remission in Early Systemic Antineutrophil Cytoplasmic Antibody–Associated Vasculitis (NORAM), Arthritis Rheum, 8, 2461, 10.1002/art.21142 Pagnoux, 2008, Azathioprine or methotrexate maintenance for ANCA-associated vasculitis, N Eng J Med, 359, 2790, 10.1056/NEJMoa0802311 Hiemstra, 2009, Randomized trial of mycophenolate mofetil vs azathioprine for maintenance therapy in ANCA-associated vasculitis (IMPROVE), APMIS, 117, 77 Silva, 2010, Mycophenolate mofetil for induction and maintenance of remission in microscopic polyangiitis with mild to moderate renal involvement. A prospective open-label pilot trial, Clin J Am Soc Nephrol, 5, 445, 10.2215/CJN.06010809 Metzler, 2007, Elevated relapse rate under oral methotrexate versus leflunomide for maintenance of remission in Wegener's granulomatosis, Rheumatology, 46, 1087, 10.1093/rheumatology/kem029 Villa-Forte, 2010, European League against rheumatism/European vasculitis study group recommendations for the management of vasculitis, Curr Opin Rheumatol, 22, 49, 10.1097/BOR.0b013e328332c9d1 Rhee, 2010, Rituximab as maintenance therapy for anti-neutrophil cytoplasmic antibody-associated Vasculitis, Clin J Am Soc Nephrol, 5, 1394, 10.2215/CJN.08821209 Martínez, 2008, Intravenous immunoglobulin for relapses of systemic vasculitides associated with antineutrophil cytoplasmic autoantibodies: results of a multicenter, prospective, open-label study of twenty-two patients, Arthritis Rheum, 58, 308, 10.1002/art.23147